AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05838703 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: tiotropium bromide inhalation powder (Spiriva HandiHaler)
Description: Spiriva HandiHaler is a COPD medication that is available for use.
Study NCT05838703 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tiotropium bromide (Spiriva Respimat)
Description: Spiriva Respimat is a COPD medication that is available for use.
Study NCT05838703 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyperpolarized 129XeMRI
Description: Xe129 hyperpolarized with use of MRI for evaluation of lung ventilation has recently been FDA approved
Study NCT05838703 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hyperpolarized 129XeMRI
Description: Xe129 hyperpolarized with use of MRI for evaluation of lung ventilation has recently been FDA approved
Study NCT05408858 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LGBTQ-affirmative cognitive behavioral group therapy
Description: 10 sessions of supportive, LGBTQ-affirmative psychotherapy
Study NCT05851469 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Prototype 0.5
Description: Investigational Medical Device collecting Raman data from tissue
Study NCT04994041 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle plus adductor strengthening
Description: 20 sessions of pelvic floor muscle strengthening plus adductor is strengthening
Study NCT04994041 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic floor muscle exercises
Description: 20 sessions of pelvic floor muscle strengthening
Study NCT06560242 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Speech discrimination
Description: Two different speech sounds are played at the same sound intensity.
Study NCT05104918 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vortioxetine
Description: 10 mg tablets
Study NCT05104918 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Venlafaxine
Description: 75 mg tablets
Study NCT05732857 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: valveless trocar
Description: the valveless trocar will be used instead of the standard trocar - these trocars are used for insufflation of carbon dioxide into the abdomen
Study NCT04723251 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: taking photographs
Description: Participants will photograph images (using a cell phone) that invoke a feeling of gratitude. At least 1 photograph (at any time of the day) should be taken for a period of three weeks.~Once the photo images are captured, the participant should spend a moment looking at the image and reflecting on why they are grateful for the subject of the photograph.
Study NCT05732857 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: standard trocar
Description: standard trocar, usually camera port for robotic surgery
Study NCT05295563 — intervention group
Intervention type: OTHER
Intervention: Evaluation
Description: Gastrocnemius muscle morphology (cross-sectional area, muscle thickness, fascicle length, pennation angle), muscle stiffness, muscle vascularization and functionality of children with CP will be evaluated.
Study NCT03904342 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Sophie CBT System
Description: The Sophie CBT system is a tablet-based system that delivers self-paced cognitive behavioral therapy educational curriculum in the format of 6 discrete modules.
Study NCT03904342 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: iHope CBT
Description: Licensed therapists will use the iHope HIPAA-compliant telemedicine platform to deliver cognitive behavioral therapy to patients via telephone, videoconferencing, and/or text chat.
Study NCT05586854 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hydrolink NV membrane
Description: patient dialysis on a Hydrolink-NV® membrane with an anticoagulant dose decrease protocol.~Period 1 : conventional membrane with his usual anticoagulant for 4 weeks. Period 2 : Hydrolink-NV® membrane with maintenance of the previous doses of Orgaran® Period 3 : Hydrolink-NV® membrane with a decrease in Orgaran® Period 4 : Hydrolink-NV® membrane with the minimum effective dose of Orgaran® or without Orgaran® for a period of 3 months (M4, M5, M6).
Study NCT04947202 — intervention group
Intervention type: DEVICE
Intervention: Hernioplasty
Description: Hernioplasty is the repair of the defect using mesh patches.
Study NCT06085183 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Saline Injection 0.9%
Description: Placebo
Study NCT06085183 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Saline Injection 0.9%
Description: Placebo
Study NCT06085183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indigotindisulfonate sodium 0.8%
Description: Experimental contrast dye that is commonly used as a visualization aid in pelvic and abdominal surgeries and for various diagnostic procedures in medical practice.
Study NCT05212025 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adavosertib
Description: Taken Orally
Study NCT05212025 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: Intravenous Infusion
Study NCT05963503 — intervention group
Intervention type: OTHER
Intervention: Assessments
Description: Health literacy Anxiety and depression Physical activity Adherence to airway clearance techniques
Study NCT05174091 — intervention group
Intervention type: OTHER
Intervention: Functional Movement Screen, Spinal Mouse, Core Endurance, Funcitonal Capacity
Description: Due to the difficulties in the diagnosis and treatment of NSLBP, it has been causing many problems such as limitation of activation, socioeconomic burden, and biopsychosocial factors for years. It is thought that the effectiveness of treatment will increase if the needs and problems of individuals with NSLBP are clearly revealed beforehand. Although there are studies on core endurance and physical capacities in individuals with NSLBP in the literature, the number of studies examining functional movement analysis and spinal mobility in individuals with NSLBP is very few. Therefore, aim of this research is to compare functional movement analysis, physical capacity, core endurance, and spinal mobility in individuals with and without NSLBP. With the results we will reveal, we aim to contribute to the evaluation and treatment of patients with NSLBP. Thus, the negative effects of this pathology, which causes serious labor and financial losses, can be minimized.
Study NCT05071898 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide Pen Injector [Ozempic]
Description: Participants will receive subcutaneously injected semaglutide (0.25 mg/wk) for 4 weeks followed by semaglutide (0.5 mg/wk) for an additional two weeks.
Study NCT05318846 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS4800 tablets
Description: Dosing frequency: single dose; Route of administration: oral
Study NCT05318846 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo tablets
Description: Dosing frequency: single dose; Route of administration: oral
Study NCT06387589 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Core stability exercises
Description: Core stability Exercises will include:~PLANK SIDE PLANK BIRD DOG MS GILL CURLUP PLANK + LEG RAISES SIDE PLANK + LEG RAISES PLANK + WALKS SIDE TO SIDE SIDE PLANK + TWIST BIRD DOG
Study NCT06387589 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Static Stretching of Iliopsoas
Description: Static Stretching of Iliopsoas (Hold for 7-8s x 10 reps) Week 1 Lifting the leg while lying in a prone position with the knee bent Week 2 Lifting the leg in a prone position with a straight knee Week 3 Stretch in the modified Thomas test position Week 4 Modified launch stretch
Study NCT06387589 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Post Facilitation Stretch of Iliopsoas
Description: Post Facilitation Stretch of Iliopsoas (5-10s x 10 reps) Patient's position supine at the edge of the table, non-effected hip and knee in flexion, experimental thigh and leg hang on the edge of table. Extend the hip of the opposite thigh up to the barrier. After that, the patient flexes the hip against maximal resistance (isometric) and breathes in for 5-10 seconds. Tell the patient Relax, whereas the therapist applies a rapid stretch to a new barrier and is held for 10 seconds.
Study NCT05955456 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention is applied to participants. The risk calculator score is not released to the participants or care providers. Participants are followed up for risk calculator accuracy and recalibration.
Study NCT05359731 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine Hydrochloride
Description: Patients will receive a total volume of 30 ml of bupivacaine 0.5% in an axillary block with a double puncture.
Study NCT05359731 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine Hydrochloride with Dexamethasone
Description: Patients will receive a total volume of 30 ml of bupivacaine 0.5% with Dexamethasone 4 mg in an axillary block with a double puncture.
Study NCT06123130 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vectorcardiography (VECG)
Description: Patients enrolled will undergo diagnostic ECG recording: three sets of simultaneous 30s recordings with the investigational device AIMIGo and a standard 12L ECG.
Study NCT04970420 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Responsibility and Family Planning ın Immigrant Women (Ahıska Turks).
Description: In this study, individual training, training via mobile application and telephone counseling will be given to the experimental group. During the meetings, attention will be paid to the pandemic rules.
Study NCT04970420 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: Individual training, mobile application and telephone counseling will be given to the control group after the study data is collected.
Study NCT06420986 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Open Hemorrhoidectomy
Description: Surgical treatment of Hemorrhoids. Removal of hemorrohids leaving the wounds open. Surgical technique described by Milligan Morgan
Study NCT06420986 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transanal Hemorrhoidal Dearterialization
Description: Surgical treatment of Hemorrhoids. This operation involves no excision. The hemorrhoidal arteries are ligated and the hemorrhoial prolapse is treated by a suture mucopexi. Described by Rato
Study NCT06317454 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood and saliva analysis
Description: Phenotyping and genotyping characterization using blood and saliva
Study NCT05488808 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: repetitive Transcranial Magnetic Stimulation
Description: Deep rTMS is delivered with the Brainsway H7-coil (Brainsway, Jerusalem, Israel) applied via a helmet placed on the head targeting the primary motor cortex of the leg.
Study NCT05488808 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: repetitive Transcranial Magnetic Stimulation
Description: Deep rTMS is delivered with the Brainsway H7-coil (Brainsway, Jerusalem, Israel) applied via a helmet placed on the head targeting the primary motor cortex of the leg.
Study NCT05472701 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diet order: WFPB, PBMA, Animal
Description: Participants followed the WFPB, PBMA, and Animal diets (in this order) for 4 weeks each.
Study NCT05472701 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: WFPB, Animal, PBMA
Description: Participants followed the WFPB, Animal, and PBMA diets (in this order) for 4 weeks each.
Study NCT05472701 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PBMA, WFPB, Animal
Description: Participants followed the PBMA, WFPB, and Animal diets (in this order) for 4 weeks each.
Study NCT05472701 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PBMA, Animal, WFPB
Description: Participants followed the PBMA, Animal, and WFPB diets (in this order) for 4 weeks each.
Study NCT05472701 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Animal, WFPB, PBMA
Description: Participants followed the Animal, WFPB, and PBMA diets (in this order) for 4 weeks each.
Study NCT05472701 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Animal, PBMA, WFPB
Description: Participants followed the Animal, PBMA, and WFPB diets (in this order) for 4 weeks each.
Study NCT04931602 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Biochemical markers i.e. Serum Ca, PTH, CTX, Albumin, Phosphate, Vitamin D and Bone mineral density Scan
Description: investigations for secondary causes of osteoporosis
Study NCT04727541 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bintrafusp alfa
Description: Neoadjuvant therapy with bintrafusp alfa
Study NCT04698928 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Theta burst stimulation
Description: Theta burst stimulation over SMA. 3 section per day, for 5 days, total 15 sections.
Study NCT05878028 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: L-TIL, Tislelizumab, Docetaxel
Description: PD1 positive lymphocytes were collect, isolated, and expanded from peripheral blood, then infused back into the patient's body. Besides this, Tislelizumab and Docetaxel were used as combination therapy.
Study NCT05017545 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: carfilzomib
Description: Administered: Intravenously (IV). Carfilzomib is administered intravenously, on two consecutive days, each week for three weeks per cycle. In this study, subjects will receive 2 cycles of carfilzomib. Dosing for each cycle is based on the recommended dosing for carfilzomib monotherapy in the package insert.~Carfilzomib is a proteasome inhibitor indicated for the treatment of patients with multiple myeloma. In this study, carfilzomib will be used in highly sensitized subjects without myeloma who are awaiting a kidney transplant.
Study NCT05017545 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: belatacept
Description: Administered: Intravenously (IV). Belatacept is indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant. In this study, belatacept will be used in highly sensitized subjects who are awaiting a kidney transplant.
Study NCT05938049 — intervention group
Intervention type: DEVICE
Intervention: IVC ultrasound & Carotid doppler
Description: bed side ultrasonographic assessement of inferior vena cava maximum and minimum diameters 2 to 5 cm caudal to its junction with the right atrium over a single respiratory cycle , inferior vena cava collapsibility index (IVC-CI) will calculated as (IVC max - IVC min)/IVC max).~carotid doppler assessment (2-3 cm proximal to the carotid bulb in the longitudinal plane) of corrected carotid flow time(systole time/√cycle time) ,carotid artery peak velocity variation calculated as (\[PV max- PV min\]/PV mean) × 100, where PV mean = (PV max + PV min)/2. during three consecutive respiratory cycles. as part of their routine care and assessment
Study NCT05811429 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic exercises
Description: 16 sessions for 8 weeks ,per week 2 sessions will be given.
Study NCT05017545 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone marrow aspiration
Description: Subjects will undergo a bone marrow aspiration prior to starting the study regimen and at 16 weeks after starting the study regimen. In subjects who undergo a kidney transplant during the study, another bone marrow aspiration will be done if it has been >4 weeks since the previous bone marrow aspiration.
Study NCT05078489 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Action-observation therapy
Description: Action observation therapy involves the observation and perception of human movement performed by others. The observation of actions performed by others activates in the perceiver the same neural structures responsible for the actual execution of those same actions.
Study NCT05078489 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will watch a natural landscape without any human.
Study NCT04982094 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mental Health First Aid and Relationship Building Training
Description: Relationship Building Training (RBT) is a 2 hour training session conducted live over zoom, that aims to equip business advisors the communications skills they need to enhance trustworthiness and quality of the relationship with their clients.~Mental Health First Aid (MHFA) is a certified training program. It requires 5-7 hours of online course work followed by 2 x 2.5 hour live zoom sessions, that aims to enhance mental health literacy and teach the skills needed to identify the signs of mental health conditions and to have a conversation with a person who may need professional help.~Two Booster sessions are delivered 1- and 3-months after the last MHFA session that aims to give participants the opportunity to consolidate their learning and share experiences applying the knowledge/skills gained.~Participants will also invite 2-3 of their small-business entrepreneur (SME) clients to join the study and complete 3 surveys to provide feedback on the success of the program.
Study NCT04982094 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mental Health First Aid
Description: Mental Health First Aid (MHFA) is a certified training program. It requires 5-7 hours of online course work followed by 2 x 2.5 hour live zoom sessions in addition to online reading, that aims to enhance mental health literacy and teach the skills needed to identify the signs of mental health conditions and to have a conversation with a person who may need professional help.~MHFA online training is conducted two-weeks before the two MHFA sessions (with a 1 day break in between each MHFA). Two Booster sessions are delivered 1- and 3-months after the last MHFA session. The Booster sessions aims to give participants the opportunity to consolidate their learning and share experiences applying the knowledge/skills gained.~Participants will also invite 2-3 of their small-business entrepreneur (SME) clients to join the study and complete 3 surveys to provide feedback on the success of the program.
Study NCT06458764 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: none, it's a incidence-prevalence study
Study NCT06292897 — intervention group
Intervention type: OTHER
Intervention: observational study
Description: observational study
Study NCT05873712 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples
Study NCT05873712 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo BM biopsy
Study NCT05873712 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT and/or PET/CT
Study NCT05873712 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV
Study NCT05873712 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV
Study NCT05873712 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Leukapheresis
Description: Given IV
Study NCT05873712 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Lisocabtagene Maraleucel
Description: Given IV
Study NCT05873712 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lymph Node Biopsy
Description: Undergo lymph node biopsy
Study NCT06366581 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Transcriptomic analysis
Description: high-throughput sequencing technology
Study NCT05321316 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-FDG
Description: All study participants will undergo one 18F-FDG PET/CT scan.
Study NCT05041127 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Given IV
Study NCT05041127 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06561750 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rooibos tea
Description: Participants will be subjected to 12 g of rooibos tea per 1200 ml of freshly boiled water
Study NCT06561750 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Participants will be subjected to 12 g per 1200 ml of freshly boiled water which is equivalent to 6 cups of tea
Study NCT06562166 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: online adaptive radiotherapy
Description: Patients in ART group received daily online adaptive radiotherapy with a prescription dose of 50.4Gy/28f.
Study NCT05975697 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental group to be applied FES
Description: In the first 24 hours after the thrombectomy procedure, the relatives of the patients in the experimental and control groups who meet the inclusion criteria will be informed by the researcher and their consent will be obtained.~FES treatment to the deltoid, triceps, extensor carpi radialis muscles for a total of 10 sessions, 30 minutes twice a day (in the morning and in the evening), for 5 days after the first 24th hour after the thrombectomy procedure in the experimental group patients (Program duration is 15 minutes and resting time is 15 minutes). minutes) will be applied.Patient information form (Appendix 1), Fugl-meyer upper extremity motor assessment scale (Appendix-2) and Quick DASH (Arm, Shoulder and Hand Injury Questionnaire Short Form) (Appendix-3) were given to both groups within the first 24 hours after the thrombectomy procedure. ) will be applied. All patients will be re-evaluated before and on the 5th day after treatment.
Study NCT04913376 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hilotherapy
Description: Constant cooling device for hands and feet.